Latest Foot-and-mouth disease Stories
MarketResearchReports.Biz announces addition of new report “China Animal Vaccine Industry Report, 2012-2015” to its database. Buy the Copy of this Report Visit - http://www.marketresearchreports.biz/analysis-details/china-animal-vaccine-industry-report-2012-2015 Albany, New York (PRWEB) June 17, 2013 In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory...
“China Animal Vaccine Industry Report, 2012-2015” and “Research on China’s Animal Vaccine Industry, 2013-2017” are new research report available at ReportsnReports.com store. Dallas, Texas (PRWEB) June 15, 2013 In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Beginning in 2004, it has gradually included highly pathogenic avian...
GAITHERSBURG, Md., March 22, 2013 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the fourth quarter and year ended December 31, 2012. For the year ended December 31, 2012, the Company reported a net loss of $14.1 million, or $1.09 per share, compared with a net loss of $7.4 million, or $0.58 per share, for the year ended December 31, 2011. GenVec ended the year with $15.3 million in cash, cash equivalents, and short-term investments. "In 2012 we...
GAITHERSBURG, Md., March 12, 2013 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) announced today that Cindy Collins, GenVec's President and CEO, will present a Company overview highlighting recent developments starting at 4:00 p.m. PDT/7:00 p.m. EDT on Tuesday, March 19th at the upcoming 25th Annual ROTH OC Growth Stock Conference in Laguna Niguel, California. A webcast of Ms. Collins' presentation will be available both live and on replay. The presentation will be available via...
Lee Rannals for redOrbit.com - Your Universe Online Diamond Light Source, the United Kingdom's national synchrotron facility, will be helping scientists shine a little more light on serious viruses, such as those responsible for AIDS, with its new laboratory, Crystal. The new laboratory uses intense X-rays to help reveal the molecular and atomic structure of objects and materials, helping scientists to see the inner workings of pathogens and infections. "Crystal provides unique...
KVISTGARD, Denmark, November 14, 2012 /PRNewswire/ -- Bavarian Nordic A/S (NASDAQ OMX: BAVA) announced today that the U.S. Department of Homeland Security (DHS) Science and Technology Directorate and the National Institutes of Health (NIH) have awarded the company two new contracts valued at up to $18.9 million for the development of recombinant Modified Vaccinia virus Ankara (MVA)-based vaccines, building on the company's MVA-BN(R) platform. The NIH contract, valued at up to...
GAITHERSBURG, Md., Nov. 9, 2012 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the three months and nine months ended September 30, 2012. GenVec reported a net loss of $4.0 million, or $0.31 per share for the three months ended September 30, 2012, compared with a net loss of $1.5 million, or $0.11 per share, in the comparable quarter of 2011. For the nine months ended September 30, 2012, GenVec's net loss was $10.9 million, or $0.84 per share,...
Study considers how to manage epidemics in information blackouts When foot-and-mouth disease swept through the British countryside in early 2001, more than 10 million sheep, cattle and pigs were slaughtered to control the disease. Despite the devastation, the disease was contained within ten months in part owing to the availability in that country of finely detailed farm data, which enabled mathematical modelers to make accurate predictions about the spread of the disease and suggest...
GAITHERSBURG, Md., Aug. 9, 2012 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the three months and six months ended June 30, 2012. GenVec reported a net loss of $3.7 million, or $0.28 per share, compared with a net loss of $1.2 million, or $0.10 per share, in the comparable quarter of 2011. For the six months ended June 30, 2012, GenVec's net loss was $6.9 million, or $0.53 per share, compared to a net loss of $3.5 million, or $0.27 per share, for...
GAITHERSBURG, Md., Aug. 2, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the second quarter ended June 30, 2012 on Thursday, August 9, 2012, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the Company's second quarter financial results and business outlook. To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980...
Latest Foot-and-mouth disease Reference Libraries
Orf, an exanthemous disease, is caused by a parapox virus primarily occurring in sheep and goats. It has many other names including thistle disease, scabby mouth, and sheep pox. It can infect humans as well. It is a zoonotic disease meaning that humans contract the disease through direct contact with infected animals. Generally there are no systemic symptoms. The finger, hand, arm, face, and genitals can be infected locations. Due to this it is important to practice proper hygiene and...
Foot-and-mouth disease, FMD, is sometimes fatal and is highly contagious for cloven-hoofed animals. Along with hooved animals hedgehogs and elephants are susceptible to the disease as well. Llama and alpaca can develop mild symptoms but are resistant to the disease and don't pass it to other species. Mice, rats, and chickens have been infected artificially in a lab but it is not believed they can contract the disease under natural conditions. Humans can spread the disease by carrying the...
